Serologic diagnosis of NMO
Top Cited Papers
- 28 February 2012
- journal article
- research article
- Published by Ovid Technologies (Wolters Kluwer Health) in Neurology
- Vol. 78 (9), 665-671
- https://doi.org/10.1212/wnl.0b013e318248dec1
Abstract
Objectives: Neuromyelitis optica (NMO) immunoglobulin G (IgG) (aquaporin-4 [AQP4] IgG) is highly specific for NMO and related disorders, and autoantibody detection has become an essential investigation in patients with demyelinating disease. However, although different techniques are now used, no multicenter comparisons have been performed. This study compares the sensitivity and specificity of different assays, including an in-house flow cytometric assay and 2 commercial assays (ELISA and transfected cell-based assay [CBA]). Methods: Six assay methods (in-house or commercial) were performed in 2 international centers using coded serum from patients with NMO (35 patients), NMO spectrum disorders (25 patients), relapsing-remitting multiple sclerosis (39 patients), miscellaneous autoimmune diseases (25 patients), and healthy subjects (22 subjects). Results: The highest sensitivities were yielded by assays detecting IgG binding to cells expressing recombinant AQP4 with quantitative flow cytometry (77; 46 of 60) or visual observation (CBA, 73%; 44 of 60). The fluorescence immunoprecipitation assay and tissue-based immunofluorescence assay were least sensitive (48%–53%). The CBA and ELISA commercial assays (100% specific) yielded sensitivities of 68% (41 of 60) and 60% (36 of 60), respectively, and sensitivity of 72% (43 of 60) when used in combination. Conclusions: The greater sensitivity and excellent specificity of second-generation recombinant antigen-based assays for detection of NMO-IgG in a clinical setting should enable earlier diagnosis of NMO spectrum disorders and prompt initiation of disease-appropriate therapies.Keywords
This publication has 19 references indexed in Scilit:
- Strategy for anti-aquaporin-4 auto-antibody identification and quantification using a new cell-based assayClinical Immunology, 2011
- Aquaporin-4 Antibodies in Neuromyelitis Optica and Longitudinally Extensive Transverse MyelitisArchives of Neurology, 2008
- Neuromyelitis optica and anti-aquaporin-4 antibodies measured by an enzyme-linked immunosorbent assayJournal of Neuroimmunology, 2008
- Pathogenic potential of IgG binding to water channel extracellular domain in neuromyelitis opticaNeurology, 2007
- The spectrum of neuromyelitis opticaThe Lancet Neurology, 2007
- Anti-aquaporin-4 antibody is involved in the pathogenesis of NMO: a study on antibody titreBrain, 2007
- NMO-IgG in the diagnosis of neuromyelitis opticaNeurology, 2007
- Revised diagnostic criteria for neuromyelitis opticaNeurology, 2006
- Establishment of a New Sensitive Assay for Anti-Human Aquaporin-4 Antibody in Neuromyelitis OpticaThe Tohoku Journal of Experimental Medicine, 2006
- A serum autoantibody marker of neuromyelitis optica: distinction from multiple sclerosisThe Lancet, 2004